drugset / Trial / NCT02219087

Liposomal Bupivacaine Versus Standard of Care in Total Knee Surgery

NCT02219087

Completed 60 enrolled OhioHealth
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to determine whether liposomal bupivacaine is effective in the management of pain following total knee arthroplasty, as compared to standard of care analgesia.

Timeline

Start
2014-08
Primary completion
2016-03
Completion
2016-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 60 ml Other
Comparator Ketorolac Other / unclassified 30 mg Other
Comparator Methylprednisolone Other / unclassified 40 mg Other
Comparator Morphine Other / unclassified 10 mg Other
Comparator Ropivacaine Other / unclassified 20 ml Other

Indications